Current Status
Not Enrolled
Enroll in this course to get access
Price
NZ$99.00
Get Started
Course Content
Course Objectives
Course Objectives
You don't currently have access to this content
Section 1: Core Principles of Safe and Ethical Prescribing
1.1 Prescribing as a High-Risk Professional Activity
You don't currently have access to this content
1.2 Prescribing as Professional Judgement, Not a Technical Task
You don't currently have access to this content
1.3 The Relationship Between Prescribing and Patient Trust
You don't currently have access to this content
1.4 Ethical Principles Underpinning Safe Prescribing
You don't currently have access to this content
1.5 Prescribing Within a Wider Medicines Management System
You don't currently have access to this content
1.6 Common System and Human Factors Affecting Prescribing
You don't currently have access to this content
1.7 Prescribing and Professional Accountability
You don't currently have access to this content
1.8 Regulatory Expectations in New Zealand
You don't currently have access to this content
1.9 Why Prescribing Concerns Escalate Quickly
You don't currently have access to this content
1.10 The Purpose of This Course
You don't currently have access to this content
1.11 Reflective Quiz
You don't currently have access to this content
Section 2: Prescribing Within Scope, Competence, and Authority
2.1 What “Scope of Practice” Means in Prescribing
You don't currently have access to this content
2.2 Scope Is Profession-Specific and Role-Specific
You don't currently have access to this content
2.3 Legal Authority Versus Professional Competence
You don't currently have access to this content
2.4 Recognising Personal Limits in Prescribing
You don't currently have access to this content
2.5 Seeking Advice, Supervision, and Referral
You don't currently have access to this content
2.6 Prescribing in New, Expanded, or Transitional Roles
You don't currently have access to this content
2.7 Prescribing Outside Scope as a Regulatory Concern
You don't currently have access to this content
2.8 Shared-Care Arrangements and Prescribing Responsibility
You don't currently have access to this content
2.9 Prescribing Under Pressure or Expectation
You don't currently have access to this content
2.10 Documenting Scope and Competence Decisions
You don't currently have access to this content
2.11 Regulatory Expectations in New Zealand
You don't currently have access to this content
2.12 Reflective Quiz
You don't currently have access to this content
Section 3: Patient-Centred Prescribing and Shared Decision-Making
3.1 What Patient-Centred Prescribing Means in Practice
You don't currently have access to this content
3.2 Shared Decision-Making as a Professional Standard
You don't currently have access to this content
3.3 Explaining Risks, Benefits, and Uncertainty
You don't currently have access to this content
3.4 Managing Patient Expectations and Requests for Medicines
You don't currently have access to this content
3.5 Prescribing When Patients Decline or Are Ambivalent
You don't currently have access to this content
3.6 Vulnerable Patients and Prescribing Decisions
You don't currently have access to this content
3.7 Cultural Safety and Prescribing in New Zealand
You don't currently have access to this content
3.8 Adherence, Monitoring, and Follow-Up
You don't currently have access to this content
3.9 Documentation of Shared Decision-Making
You don't currently have access to this content
3.10 Regulatory Perspective on Patient-Centred Prescribing
You don't currently have access to this content
3.11 Common Pitfalls in Patient-Centred Prescribing
You don't currently have access to this content
3.12 Reflective Quiz
You don't currently have access to this content
Section 4: High-Risk Medicines and Controlled Drugs
4.1 Why Some Medicines Carry Higher Prescribing Risk
You don't currently have access to this content
4.2 What Is Meant by “High-Risk Medicines”
You don't currently have access to this content
4.3 Controlled Drugs and Regulatory Scrutiny
You don't currently have access to this content
4.4 Assessing Indication and Alternatives
You don't currently have access to this content
4.5 Managing Risk of Dependence, Misuse, and Diversion
You don't currently have access to this content
4.6 Monitoring, Review, and Deprescribing
You don't currently have access to this content
4.7 Documentation of High-Risk Prescribing Decisions
You don't currently have access to this content
4.8 Prescribing Under Pressure or Expectation
You don't currently have access to this content
4.9 Shared-Care and Specialist-Initiated Prescriptions
You don't currently have access to this content
4.10 Regulatory Perspective in New Zealand
You don't currently have access to this content
4.11 Common Pitfalls in High-Risk Prescribing
You don't currently have access to this content
4.12 Reflective Quiz
You don't currently have access to this content
Section 5: Self-Prescribing and Prescribing for Family, Friends, and Colleagues
5.1 Why Self-Prescribing and Informal Prescribing Are High-Risk
You don't currently have access to this content
5.2 Loss of Objectivity and Professional Distance
You don't currently have access to this content
5.3 Absence of Proper Clinical Assessment
You don't currently have access to this content
5.4 Documentation and Monitoring Failures
You don't currently have access to this content
5.5 Prescribing for Family Members
You don't currently have access to this content
5.6 Prescribing for Friends, Colleagues, or Staff
You don't currently have access to this content
5.7 Emergency Situations: The Limited Exception
You don't currently have access to this content
5.8 Controlled Drugs and High-Risk Medicines
You don't currently have access to this content
5.9 Regulatory Expectations in New Zealand
You don't currently have access to this content
5.10 How Regulators Assess These Cases
You don't currently have access to this content
5.11 Professional Alternatives to Informal Prescribing
You don't currently have access to this content
5.12 Learning From Cases Involving Informal Prescribing
You don't currently have access to this content
5.13 Reflective Quiz
You don't currently have access to this content
Section 6: Documentation, Monitoring, and Review of Prescriptions
6.1 Why Documentation Is Central to Safe Prescribing
You don't currently have access to this content
6.2 What Good Prescribing Documentation Should Include
You don't currently have access to this content
6.3 Documenting High-Risk Prescribing Decisions
You don't currently have access to this content
6.4 Repeat Prescribing and Ongoing Responsibility
You don't currently have access to this content
6.5 Monitoring After Prescribing
You don't currently have access to this content
6.6 Review, Deprescribing, and Stopping Medicines
You don't currently have access to this content
6.7 Shared-Care Prescribing and Monitoring Responsibilities
You don't currently have access to this content
6.8 Documentation of Advice and Safety-Netting
You don't currently have access to this content
6.9 Electronic Prescribing Systems and Pitfalls
You don't currently have access to this content
6.10 Regulatory Expectations in New Zealand
You don't currently have access to this content
6.11 Common Documentation and Monitoring Failures
You don't currently have access to this content
6.12 Reflective Quiz
You don't currently have access to this content
Section 7: Prescribing Errors, Near Misses, and Adverse Events
7.1 Understanding Prescribing Errors in Context
You don't currently have access to this content
7.2 Near Misses as Critical Learning Opportunities
You don't currently have access to this content
7.3 Adverse Drug Events and Prescribing Responsibility
You don't currently have access to this content
7.4 Common Contributing Factors to Prescribing Errors
You don't currently have access to this content
7.5 Responding Immediately When an Error Is Identified
You don't currently have access to this content
7.6 Duty of Candour and Open Communication
You don't currently have access to this content
7.7 Reporting, Learning, and System Improvement
You don't currently have access to this content
7.8 Prescribing Errors and Professional Accountability
You don't currently have access to this content
7.9 When Errors Escalate to Complaints or Investigations
You don't currently have access to this content
7.10 Regulatory Perspective in New Zealand
You don't currently have access to this content
7.11 Common Pitfalls After Prescribing Errors
You don't currently have access to this content
7.12 Reflective Quiz
You don't currently have access to this content
Section 8: Prescribing-Related Complaints, Audits, and Investigations
8.1 Why Prescribing Concerns Frequently Lead to Complaints
You don't currently have access to this content
8.2 Understanding the Difference Between Complaints, Audits, and Investigations
You don't currently have access to this content
8.3 Common Triggers for Prescribing Audits
You don't currently have access to this content
8.4 How Investigators Assess Prescribing Practice
You don't currently have access to this content
8.5 Documentation as Central Evidence
You don't currently have access to this content
8.6 Professional Behaviour During Complaints and Investigations
You don't currently have access to this content
8.7 Candour, Apology, and Communication
You don't currently have access to this content
8.8 Patterns, Repetition, and Escalation
You don't currently have access to this content
8.9 Regulatory Perspective in New Zealand
You don't currently have access to this content
8.10 Using Audits and Investigations as Learning Opportunities
You don't currently have access to this content
8.11 Avoiding Common Mistakes During Investigations
You don't currently have access to this content
8.12 Reflective Quiz
You don't currently have access to this content
Section 9: Regulatory Expectations, Insight, and Remediation After Prescribing Concerns
9.1 Why Prescribing Concerns Are Assessed as Trust Issues
You don't currently have access to this content
9.2 Fitness to Practise: A Forward-Looking Assessment
You don't currently have access to this content
9.3 How Regulators Assess Prescribing Behaviour
You don't currently have access to this content
9.4 Insight as the Cornerstone of Regulatory Reassurance
You don't currently have access to this content
9.5 Honesty and Candour After Prescribing Errors
You don't currently have access to this content
9.6 What Meaningful Remediation Looks Like in Prescribing Cases
You don't currently have access to this content
9.7 Behaviour Change: The Most Persuasive Evidence
You don't currently have access to this content
9.8 Supervision, Mentoring, and Ongoing Support
You don't currently have access to this content
9.9 Timing and Proactivity in Remediation
You don't currently have access to this content
9.10 When Regulatory Trust Is Considered Restored
You don't currently have access to this content
9.11 Reflective Quiz
You don't currently have access to this content
Section 10: Conclusion and Key Takeaways
Conclusion and Key Takeaways
You don't currently have access to this content
Post-Course Assessment
You don't currently have access to this content